Following @ to @mg once daily dosing , TA-@ demonstrated nearly complete inhibition of CETP activity ( @-@ % ) , increased high density lipoprotein-cholesterol ( HDL-C ) by @ to @ % and decreased low density liporotein-cholesterol ( LDL-C ) by @ % to @ % .